Dáil Éireann Debate, Tuesday - 16 May 2017
81. Deputy Maurice Quinlivan asked the Minister for Jobs, Enterprise and Innovation the steps she is taking to attract companies that have to relocate some of their operations from Britain to an EU member state; and her views on whether Ireland could secure the relocation of the European Medicines Agency. [23032/17]
View answerThe IDA continues to work hard to both identify and pursue new opportunities for foreign direct investment (FDI) for Ireland that may arise on account of Brexit. This process involves engaging with potential clients, both at home and abroad, in connection with various issues associated with locating or expanding here.
As Minister for Jobs, Enterprise and Innovation, I work closely with the Agency in support of their efforts to win new FDI - whether Brexit-related or not - for the country. Two weeks ago, for example, I participated in an IDA marketing and investment programme to the United States aimed at attracting more business to Ireland.
As regards the European Medicines Agency (EMA), I believe Ireland is strongly placed to become its new home. The strengths of our bid are well known, including our world-class workforce, dynamic life sciences sector and the fact that relocation here would represent the least disruptive option for the EMA. We will continue, across Government, to promote Ireland as the ideal new location for the Agency.
